Cargando…

Whole exome sequencing in systemic juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales:	Moghaddas, F, De Nardo, D, Baker, P, Gordon, L, Sadedin, S, Oshlack, A, Akikusa, J, Allen, R, Munro, J, Ellis, J, Masters, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597296/ http://dx.doi.org/10.1186/1546-0096-13-S1-O2

Ejemplares similares

A juvenile idiopathic arthritis biobank at the Royal Children's Hospital, Melbourne, Australia
por: Ellis, J, et al.
Publicado: (2008)

CLARITY: ChiLdhood Arthritis Risk Factor Identification STudY. Investigating the role of aberrant DNA methylation in juvenile idiopathic arthritis
por: Ellis, JA, et al.
Publicado: (2011)

PReS-FINAL-2149: Interaction of PTPN2 and vitamin D GC sequence variants and risk of juvenile idiopathic arthritis
por: Ellis, JA, et al.
Publicado: (2013)

Identification of rare genetic variants in Juvenile Idiopathic Arthritis using whole exome sequencing
por: Sanchez, E, et al.
Publicado: (2015)

Preliminary study of regionalised centre-of-pressure analysis in patients with juvenile idiopathic arthritis
por: Hendry, Gordon J, et al.
Publicado: (2012)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Safety and efficacy of ultrasound guided corticosteroid injections into temporomandibular joints in children with active juvenile idiopathic arthritis
por: Habibi, S, et al.
Publicado: (2011)

Ximmer: a system for improving accuracy and consistency of CNV calling from exome data
por: Sadedin, Simon P, et al.
Publicado: (2018)

3.4 Physical activity in adolescents with juvenile idiopathic arthritis
por: Lelieveld, OTHM, et al.
Publicado: (2008)

Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis
por: Zholobova, Elena, et al.
Publicado: (2014)

Application of a novel multi-segment foot model to assess foot function in children and adolescents with juvenile idiopathic arthritis
por: Hendry, Gordon J, et al.
Publicado: (2011)

Frequent discordance between clinical and musculoskeletal ultrasound examinations of foot disease in juvenile idiopathic arthritis observed in the multidisciplinary setting
por: Hendry, Gordon J, et al.
Publicado: (2011)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
por: Van Dijkhuizen, Pieter E H, et al.
Publicado: (2011)

Juvenile idiopathic arthritis is associated with potentially pathogenic glycosylation of IgG
por: Ercan, Altan, et al.
Publicado: (2012)

Monocytes and neutrophils in the inflammatory cascade of systemic onset Juvenile Idiopathic Arthritis
por: ter Haar, N, et al.
Publicado: (2015)

Systemic juvenile idiopathic arthritis is associated with HLA-DRB1 in Europeans and Americans of European descent
por: Ombrello, Michael, et al.
Publicado: (2012)

To evaluate the impact of a nurse-led JIA education program on parental satisfaction regarding knowledge of JIA and its management
por: Jones, J, et al.
Publicado: (2011)

DNA methylation at IL32 in juvenile idiopathic arthritis
por: Meyer, Braydon, et al.
Publicado: (2015)

14.3 Early cardiovascular risk assessment in patients with juvenile idiopathic arthritis
por: Vlahos, AP, et al.
Publicado: (2008)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
por: Hunter, PJ, et al.
Publicado: (2008)

PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2013)

Independent replication analysis of genetic loci with previous evidence of association with juvenile idiopathic arthritis
por: Ellis, Justine A, et al.
Publicado: (2013)

The risk and nature of flares in juvenile idiopathic arthritis: results from the reACCh-Out cohort
por: Guzman, Jaime, et al.
Publicado: (2014)

Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
por: Horneff, G, et al.
Publicado: (2015)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

Musculoskeletal ultrasound versus magnetic resonance in supporting clinical management of juvenile idiopathic arthritis
por: Lanni, Stefano, et al.
Publicado: (2014)

Two year remission rates and functional outcomes in an inception cohort of Canadian children with juvenile idiopathic arthritis
por: Tse, Shirley ML, et al.
Publicado: (2012)

OA30 Genetic analysis of whole exome sequencing in a cohort of children with refractory JIA reveals genetic risk factors for rare juvenile diseases
por: Tordoff, Melissa, et al.
Publicado: (2022)

Patients with early-onset systemic juvenile idiopathic arthritis show more inflammation and worse outcome
por: Russo, R, et al.
Publicado: (2011)

Development of new classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Minoia, Francesca, et al.
Publicado: (2014)

Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children
por: Tiller, Georgina, et al.
Publicado: (2018)

7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
por: Ruperto, N, et al.
Publicado: (2008)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
por: Yokota, S, et al.
Publicado: (2008)

Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2011)

YIM-O13. Development of novel protein biomarkers for the prediction of response to treatment in juvenile idiopathic arthritis
por: Palman, Jason, et al.
Publicado: (2014)

14.5 Rheumatoid Arthritis susceptibility loci; STAT4, TRAF1/C5 and 6q23 region, are also associated with Juvenile Idiopathic Arthritis
por: Hinks, A, et al.
Publicado: (2008)

2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis
por: Malattia, C, et al.
Publicado: (2008)

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Davì, Sergio, et al.
Publicado: (2011)

SpineCore treatment for juvenile idiopathic scoliosis
por: Coillard, Christine, et al.
Publicado: (2010)

Tapering and withdrawal of tocilizumab in patients with systemic juvenile idiopathic arthritis in inactive disease: results from an alternative dosing regimen in the TENDER study
por: De Benedetti, F, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iejenib9niucnqmjtlh31f68fc